Back to Search
GIORGIO INGHIRAMI, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1962496125IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
194939(NY)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
194939(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1981
Research & Publications (20)
New and old functions of STAT3: a pivotal target for individualized treatment of cancer.
PMID 16082218·Cell Cycle·2005
6-review
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.
PMID 19404216·J Thorac Oncol·2009
8-other
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
PMID 19358142·Hematol Oncol·2009
6-review
Anaplastic lymphoma kinase: an oncogene for tumor vaccination.
PMID 19330473·J Mol Med (Berl)·2009
6-review
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
PMID 18845790·Blood·2009
8-other
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.
PMID 18974134·Cancer Res·2008
7-preclinical
The anaplastic lymphoma kinase in the pathogenesis of cancer.
PMID 18097461·Nat Rev Cancer·2008
6-review
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination.
PMID 18469826·Nat Med·2008
7-preclinical
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
PMID 18057228·Blood·2008
7-preclinical
Identification and validation of the anaplastic large cell lymphoma signature.
PMID 17695725·Adv Exp Med Biol·2007
7-preclinical
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
PMID 17483340·Cancer Res·2007
8-other
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
PMID 16951165·Cancer Res·2006
7-preclinical
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
PMID 16901783·Cell·2006
7-preclinical
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas.
PMID 16189272·Blood·2006
7-preclinical
Increase in circulating bone marrow progenitor cells after myocardial infarction.
PMID 16707957·Coron Artery Dis·2006
8-other
Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia.
PMID 16831041·Arch Pathol Lab Med·2006
5-case
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.
PMID 17111047·J Clin Invest·2006
7-preclinical
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.
PMID 16105984·Blood·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE, 10 U
NEW YORK, NY 10016 - Phone
- (212) 263-5687
Quick Facts
- NPI
- 1962496125
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile